Last Updated : February 8, 2008
Details
FilesGeneric Name:
Duloxetine hydrochloride
Project Status:
Complete
Therapeutic Area:
Pain, Neuropathic, Diabetic
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Cymbalta
Project Line:
Reimbursement Review
Project Number:
SR0126-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Pain, Neuropathic, Diabetic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 8, 2008